With the rapidly evolving regulatory landscape, staying on top of the latest updates is crucial for companies in biopharma and medical devices.

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Former National Institutes of Health Director Dr. Francis Collins, who abruptly left his NIH research lab in February, fears ...

A researcher at Boston University is keeping tabs on deaths likely caused by dismantling U.S. foreign aid programs ...

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost ...

In three years, six of Vermont’s Planned Parenthood Health Centers have closed. What is contributing to those closures and ...

In response to funding uncertainties under Trump policies, the Medical College has also capped Ph.D. admissions and ended ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

During Joe Biden’s presidency, his administration approved roughly $600 million in grants with descriptions containing the words “men who have sex with men." ...